FAQ
Most Popular Questions
NILE SPF eggs are produced from specialized donor flocks maintained in ultra-secure facilities. These flocks are certified free from a comprehensive list of specified avian pathogens, including viruses and bacteria, as defined by international biological standards.
Our production and monitoring protocols are strictly aligned with the European Pharmacopoeia (Ph. Eur.) requirements. This ensures that our substrates meet the highest global benchmarks for vaccine manufacturing and specialized biological research.
Our products are essential for the production of human and veterinary vaccines (such as Influenza), virology research, immunology studies, and as diagnostic tools in specialized reference laboratories worldwide.
To maintain maximum embryo viability, SPF eggs should be stored at a temperature range of 12°C to 15°C with a relative humidity of 70-80%. We recommend incubation within 7 to 10 days from the date of collection for optimal results.
We utilize a multi-layered biosecurity system, including positive-pressure air filtration (HEPA), heat-treated feed, and strict "shower-in/shower-out" protocols for all personnel to prevent any lateral contamination of the flocks.
Yes. Leveraging our strategic location in Egypt, we manage global cold-chain logistics and provide all necessary international veterinary certifications and documentation required for seamless customs clearance and delivery.
Every shipment is accompanied by a detailed Certificate of Analysis (CoA). This document provides full traceability and confirms the negative test results for all required pathogens during the production period of that specific batch.
Absolutely. We work closely with pharmaceutical partners to establish long-term supply agreements and customized delivery schedules that align with their specific vaccine production cycles and research timelines.
